| Literature DB >> 29163400 |
Song Li1, Yufa Zhou2, Zengmin Miao3.
Abstract
The present study was aimed to determine the prevalence and characteristics of Salmonella isolated from meat samples of commercial broilers (CB) and spent hens (SH). Between March and June 2016, 200 retail raw chicken carcasses (100 from CB and 100 from SH) were obtained from local supermarkets in Tai'an city of China, and Salmonella isolates were then analyzed for antibiotic resistance, serotype, β-lactamase genes, and the presence of class 1 integron. Forty Salmonella strains were obtained in this study (CB: 21/100, 21%; SH: 19/100, 19%). Three serotypes were identified in 40 Salmonella, and S. Enteritidis (CB: 15/21, 71.4%; SH: 10/19, 52.6%) was the dominant serotype, followed by S. Typhimurium (CB: 4/21, 19%; SH: 6/19, 31.6%) and S. Derby (CB: 2/21, 9.5%; SH: 3/19, 15.8%). Among 21 Salmonella isolated from CB, high antibiotic resistance rates were found for ampicillin (20/21, 95.2%), nalidixic acid (18/21, 85.7%), cefotaxime (17/21, 81%), and tetracycline (13/21, 61.9%); class 1 integron was observed in seven isolates (7/21, 33.3%), and gene cassettes included an empty integron (0.15 kb, n = 1), aadA2 (1.2 kb, n = 3), drfA1-aadA1 (1.4 kb, n = 1), and drfA17-aadA5 (1.7 kb, n = 2); blaTEM-1 was the dominant β-lactamase gene (21/21, 100%), followed by blaCTX-M-55 (7/21, 33.3%). Among 19 Salmonella isolated from SH, high antibiotic resistance rates were found for nalidixic acid (19/19, 100%), tetracycline (19/19, 100%), ampicillin (18/19, 94.7%), and ciprofloxacin (13/19, 68.4%); class 1 integron was observed in two isolates (2/19, 10.5%), and gene cassettes included drfA17-aadA5 (1.7 kb, n = 1) and drfA1-aadA1 (1.4 kb, n = 1); blaTEM-1 was the dominant β-lactamase gene (19/19, 100%), followed by blaCTX-M-55 (2/19, 10.5%) and blaCMY-2 (1/19, 5.3%). Collectively, antibiotic-resistant Salmonella can be widely detected in retail raw chicken carcasses of CB and SH, and therefore can pose a serious risk to public health.Entities:
Keywords: Salmonella; antibiotic resistance; class 1 integron; serotype; β-lactamase gene
Year: 2017 PMID: 29163400 PMCID: PMC5671596 DOI: 10.3389/fmicb.2017.02106
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Antibiotic resistance phenotype, presence of class 1 integron, and β-lactamase genes in Salmonella isolated from CB.
| Isolates | Serovar | Antibiotic resistance phenotypea | Integron/β-lactamase genes |
|---|---|---|---|
| CB-1 | AMP, CIP, CTX, NAL, TET | ||
| CB-12 | AMP, GEN, CTX, FFC, NAL, TET | ( | |
| CB-14 | AMP, GEN, CTX, FFC, NAL, TET | ||
| CB-18 | AMP, CTX, NAL | ( | |
| CB-33 | AMP, GEN, CTX, FFC, NAL, TET | ||
| CB-42 | AMP, GEN, SPT | ( | |
| CB-48 | AMP, SPT | ||
| CB-49 | AMP, GEN, CTX, FFC, NAL, TET | ||
| CB-51 | AMP, CTX, NAL | ||
| CB-58 | AMP, GEN, CTX, FFC, NAL, TET | ||
| CB-59 | AMP, CTX, FFC, NAL, TET | ||
| CB-63 | AMP, GEN, CTX, FFC, NAL, TET | ( | |
| CB-65 | AMP, GEN, CTX, FFC, NAL, TET | ||
| CB-71 | AMP, GEN, CTX, FFC, NAL, TET | ( | |
| CB-79 | AMP, GEN, CTX, FFC, NAL, TET | ||
| CB-81 | AMP, SPT | ( | |
| CB-88 | NAL | ||
| CB-89 | AMP, GEN, CTX, FFC, NAL, TET | ||
| CB-91 | AMP, CIP, CTX, NAL, TET | ||
| CB-96 | AMP, CTX, NAL | empty integron/ | |
| CB-98 | AMP, CTX, NAL |
Antibiotic resistance phenotype, presence of class 1 integron, and β-lactamase genes in Salmonella isolated from SH.
| Isolates | Serovar | Antibiotic resistance phenotypeb | Integron/β-lactamase genes |
|---|---|---|---|
| SH-3 | NAL | ||
| SH-5 | AMP, NAL, TET | ||
| SH-8 | AMP, CTX, CIP, NAL, TET | ||
| SH-13 | AMP, CIP, NAL, TET | ||
| SH-21 | AMP, NAL, TET | ||
| SH-26 | AMP, NAL, TET | ||
| SH-33 | AMP, CIP, NAL, TET | ||
| SH-35 | AMP, CIP, CTX, NAL, TET | ( | |
| SH-48 | AMP, CIP, NAL, TET | ||
| SH-50 | AMP, CIP, NAL, TET | ||
| SH53 | AMP, NAL, TET | ||
| SH-61 | AMP, CTX, CIP, NAL, TET | ||
| SH-66 | AMP, CIP, NAL, TET | ||
| SH-73 | AMP, NAL, TET | ||
| SH-75 | AMP, CIP, NAL, TET | ||
| SH-88 | AMP, CIP, CTX, GEN, NAL, TET | ( | |
| SH-90 | AMP, CIP, NAL, TET | ||
| SH-93 | AMP, CIP, NAL, TET | ||
| AMP, CIP, NAL, TET |